Digest Network Come funziona
Network
/
Società
Se
Non verificato

Sensory Cloud Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

4 comunicati stampa

Guarda tutti i comunicati
23/09/2025
Biotecnologia
Attrezzature medico-sanitarie
Salute
Farmaceutica
Medicina - Varie
Sensory Cloud Announces Positive Results from the Phase 2 REACH Trial at King Saud University Medical City in Patients with Refractory Chronic Cough (RCC)
Fonte
Sensory Cloud Inc.
Emittente
Business Wire
1.00
0
20/08/2025
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Industria
Sensory Cloud Announces Positive Results in Phase 2a REACH Study in Patients with Refractory Chronic Cough (RCC)
Fonte
Sensory Cloud Inc.
Emittente
Business Wire
1.00
0
14/05/2025
Eventi
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Sanità
REACH Trial Evaluating First-Line Treatment of Refractory Chronic Cough Completes Enrollment
Fonte
Sensory Cloud Inc.
Emittente
Business Wire
1.00
0
29/10/2024
Industria
Tecnica
Scienza
Medicina - Varie
Biotecnologia
Sanità
Salute
Sensory Cloud Inc. and Hyfe Inc. Release Study on Inhaled Treatment for Refractory Chronic Cough
Fonte
Sensory Cloud Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0